PMDA inspection

Eli Lilly Japan K.K. Seishin Laboratories

PMDA inspection 5130508037951 · Japan · Suitable

Key facts

Control number 5130508037951
Manufacturing site Eli Lilly Japan K.K. Seishin Laboratories
Location 4-3-3 Takatsukadai, Nishi-ku, Kobe, Hyogo Prefecture
Country Japan
Product type Pharmaceuticals
Application type New
Inspection method Remote
Inspection month Apr 1, 2024
Result Suitable
Result notified Apr 9, 2024
PMDA registration 28AY000043
FEI numbers 3002565948

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)